Perclose Prostyle
Payments companies reported to CMS as associated with Perclose Prostyle. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Perclose Prostyle, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Perclose Prostyle
These are the largest totals companies reported as associated with Perclose Prostyle. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Derubertis | New York, NY | Vascular Surgery | $42,248.57 |
| Srinivas Tummala | Pembroke Pines, FL | Vascular & Interventional Radiology | $27,384.33 |
| John Corl | Cincinnati, OH | Interventional Cardiology | $25,254.50 |
| Jackson Liang | Ann Arbor, MI | Clinical Cardiac Electrophysiology | $23,649.81 |
| Ajit Rao | New York, NY | Vascular Surgery | $18,150.00 |
| Christian Bianchi | Loma Linda, CA | Surgery | $18,094.27 |
| Nicolas Mouawad | West Branch, MI | Vascular Surgery | $14,012.77 |
| Rajdeep Gaitonde | Louisville, KY | Clinical Cardiac Electrophysiology | $12,864.77 |
| Elizabeth Genovese | Philadelphia, PA | Vascular Surgery | $11,550.00 |
| Nadia Sutton | Nashville, TN | Interventional Cardiology | $6,618.75 |
Prescribed Perclose Prostyle?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.